Author

Everett H. Meyer

Stanford MedicineORCID 0000-0001-7953-853XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Organism:mouse· 4 Research Focus:host-pathogen & immune response· 3 Organism:human· 2 Assay:proteomics· 2 Research Focus:cancer & tumor microenvironment· 1

Frequent Co-Authors

Abigail TwoyiD· 3 shared Emily Soohoo· 3 shared Kent P. JenseniD· 3 shared Shiva PathakiD· 3 shared Avnesh Sinh ThakoriD· 2 shared Bettina Panagiota IliopoulouiD· 2 shared Biki GuptaiD· 2 shared Cameron S. BaderiD· 2 shared

Activity by Year

2025-2026 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

Abigail TwoyORCID

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Donor-derived CD8+CD122+ Tregs generated in mixed donor chimeric NOD mice suppress autoreactive T cells

Shiva Pathak, Cameron S. Bader, Bettina Panagiota Iliopoulou, Shobha Regmi, Pin-I Chen, Biki Gupta, Xiangni Wu, Blake Mosher, Alexandra Wells, Levon Witherspoon, Kayla Jenkins, William Harper, Emily Soohoo, Abigail Twoy, Rizwan Ahmed, , Everett H. Meyer

This study identifies donor-derived CD8+CD122+ Tregs in mixed chimeric NOD mice that suppress autoreactive T cells and may offer a new therapeutic strategy for autoimmune diabetes.

Journal of Clinical Investigation · Oct 27, 2026Peer-reviewedImmunology

CD38 defines a therapeutically targetable pathogenic T cell population for precision immunotherapy in autoimmune diabetes

Shiva Pathak, Rizwan Ahmed, Nadine Nagy, Sooyeon Lee, Cameron S. Bader, Shobha Regmi, Bettina Panagiota Iliopoulou, Pin-I Chen, Biki Gupta, Alejandro Villar‐Prados, Yong Bin Kim, Noor A. Hussein, Emily Soohoo, Abigail Twoy, Avnesh Sinh Thakor, , Everett H. Meyer

The paper identifies CD38 as a marker for pathogenic T cells in T1D and shows that anti-CD38 mAb selectively depletes these cells to prevent diabetes without affecting Tregs.

bioRxiv · Jul 3, 2026 · PreprintImmunology

Soluble LAG-3 Identifies a Dynamic Early T Cell Activation Window in self-reactivity, Type 1 Diabetes, and Broader Immune Responses.

Saptarshi Roy, Megan Lynn Proffer, Farooq Syed, Megan E. Smithmyer, Anup R. Sharma, Abigail Twoy, Emily Soohoo, Jyoti Rana, Jason M. Spaeth, Everett H. Meyer, Kent P. Jensen, CATE SPEAKE, William Hagopian, Jon D. Piganelli

This study identifies soluble LAG-3 (sLAG-3) as an early biomarker of T cell activation in type 1 diabetes, detectable before islet autoantibody development and associated with beta-cell stress and high-risk HLA genotypes.

bioRxiv · Apr 2, 2026 · PreprintImmunology

Curing autoimmune diabetes with islet and hematopoietic cell transplantation after CD117 antibody-based conditioning

Preksha Bhagchandani, Stephan A. Ramos, Bianca Rodriguez, Xueying Gu, Shiva Pathak, Yuqi Zhou, Yujin Moon, Nadia Nourin, Charles Chang, Jessica Poyser, Brenda J. Velasco, Weichen Zhao, Hye-Sook Kwon, Richard Rodríguez, Diego Burgos, , Seung K. Kim

This study demonstrates that non-myeloablative conditioning with anti-CD117 antibodies and HCT can induce durable mixed chimerism and cure autoimmune diabetes in NOD mice.

bioRxiv · Sep 5, 2025 · PreprintImmunology